According to the latest report by IMARC Group, titled “Thrombectomy Devices Market: Global Industry Trends, Share, Growth, Opportunity and Forecast 2023-2028,” The global thrombectomy devices market size reached US$ 1.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.8 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.
Thrombectomy devices refer to intracoronary catheters that have a central aspiration lumen through which the thrombus can be extracted. They can be of various types, such as aspiration thrombectomy devices, ultrasonic thrombectomy devices, mechanical thrombectomy devices, etc. These thrombectomy devices offer numerous benefits in surrogate endpoints, including biomarker analysis, ST-segment resolution, infarct size reduction, angiographic thrombolysis in myocardial infarction (TIMI) flow, etc. They aid in minimizing blood loss and damage caused to the vessel wall and prove highly effective in treating blood clots present in arteries, veins, and capillaries. As a result, thrombectomy devices find extensive applications in hospitals, clinics, ambulatory surgical centers, and other healthcare establishments across the globe.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Global Thrombectomy Devices Market Trends:
The escalating prevalence of several chronic diseases, such as diabetes, cardiovascular disorder, cancer, etc., on account of hectic schedules and the increased consumption of alcohol, fast food, and tobacco is among the key factors driving the thrombectomy device market. In addition to this, the growing geriatric population, the shifting preferences toward minimally invasive (MI) surgical procedures, and the increasing improvements in the healthcare infrastructure, especially in developing countries, are also positively influencing market growth. Furthermore, the inflating investments by leading manufacturers in research and development (R&D) activities to develop technologically advanced thrombectomy devices are acting as significant growth-inducing factors. Apart from this, the elevating number of approvals for new healthcare products, the launch of favorable reimbursement policies, and the rising product usage by surgeons to perform image-guided surgeries are anticipated to propel the thrombectomy devices market in the coming years.
Request Free Sample Report: https://www.imarcgroup.com/thrombectomy-devices-market/requestsample
Global Thrombectomy Devices Market 2023-2028 Analysis and Segmentation:
- Argon Medical Devices Inc
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Johnson & Johnson
- Medtronic Plc
- Penumbra Inc
- Spectranetics Corporation (Koninklijke Philips N.V.)
- Stryker Corporation
- Teleflex Incorporated
- Terumo Corporation
The report has segmented the market on the basis on region, product type, application, end user.
Breakup by Product Type:
- Aspiration Thrombectomy Devices
- Mechanical Thrombectomy Devices
- Ultrasonic Thrombectomy Devices
Breakup by Application:
- Peripheral Vascular
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Surgical Centers
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/thrombectomy-devices-market
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800